US Food and Drug Administration Safety Advisories and Reporting to the Adverse Event Reporting System (FAERS).
Thomas J MooreRichard L MorrowColin R DormuthBarbara MintzesPublished in: Pharmaceutical medicine (2021)
No consistent pattern or effect was found on spontaneous reporting following these safety advisories. After results were available, we observed that some cases with the largest reporting increase also involved substantial numbers of legal claims. Changes in adverse event reporting following a warning need to be evaluated on a case-by-case basis.